BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19:375-383. [PMID: 18624795 DOI: 10.1111/j.1750-3639.2008.00184.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, Aharonov R, Bentwich Z, Rosenfeld N, Cohen D. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010;12:771-9. [PMID: 20864637 DOI: 10.2353/jmoldx.2010.090169] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
2 Srivastava SK, Bhardwaj A, Leavesley SJ, Grizzle WE, Singh S, Singh AP. MicroRNAs as potential clinical biomarkers: emerging approaches for their detection. Biotech Histochem. 2013;88:373-387. [PMID: 23293934 DOI: 10.3109/10520295.2012.730153] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
3 Khan IN, Ullah N, Hussein D, Saini KS. Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications. Seminars in Cancer Biology 2018;52:85-102. [DOI: 10.1016/j.semcancer.2017.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 Xu T, Liu X, Han L, Shen H, Liu L, Shu Y. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol 2014;16:469-75. [DOI: 10.1007/s12094-013-1106-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
5 Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci 2014;15:21554-86. [PMID: 25421247 DOI: 10.3390/ijms151121554] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
6 Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol 2011;8:557-64. [PMID: 21697652 DOI: 10.4161/rna.8.4.16019] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
7 Tayari MM, Winkle M, Kortman G, Sietzema J, de Jong D, Terpstra M, Mestdagh P, Kroese FG, Visser L, Diepstra A, Kok K, van den Berg A, Kluiver J. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAs. Am J Pathol 2016;186:2462-72. [PMID: 27423697 DOI: 10.1016/j.ajpath.2016.05.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
8 Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol. 2010;23:814-823. [PMID: 20348879 DOI: 10.1038/modpathol.2010.57] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 7.5] [Reference Citation Analysis]
9 Caffo M, Barresi V, Caruso G, Cutugno M, La Fata G, Venza M, Alafaci C, Tomasello F. Innovative therapeutic strategies in the treatment of brain metastases. Int J Mol Sci 2013;14:2135-74. [PMID: 23340652 DOI: 10.3390/ijms14012135] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
10 Zadran S, Remacle F, Levine R. Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype. PLoS One 2014;9:e108171. [PMID: 25265448 DOI: 10.1371/journal.pone.0108171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 Cui H, Yang L. Analysis of microRNA Expression Detected by Microarray of the Cerebral Cortex After Hypoxic-Ischemic Brain Injury. Journal of Craniofacial Surgery 2013;24:2147-52. [DOI: 10.1097/scs.0b013e3182a243f3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
12 Kim DY, Hwang I, Muller FL, Paik JH. Functional regulation of FoxO1 in neural stem cell differentiation. Cell Death Differ 2015;22:2034-45. [PMID: 26470727 DOI: 10.1038/cdd.2015.123] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
13 Lau P, Hudson LD. MicroRNAs in neural cell differentiation. Brain Res 2010;1338:14-9. [PMID: 20382133 DOI: 10.1016/j.brainres.2010.04.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
14 Min L, Chen L, Liu S, Yu Y, Guo Q, Li P, Zhu S. Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage. Int J Med Sci. 2019;16:1231-1237. [PMID: 31588188 DOI: 10.7150/ijms.34540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, He ML, Kung H, Li XP. miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis 2014;35:554-63. [PMID: 24170200 DOI: 10.1093/carcin/bgt354] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
16 Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist. 2012;17:801-812. [PMID: 22618571 DOI: 10.1634/theoncologist.2011-0466] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 10.2] [Reference Citation Analysis]
17 Spector Y, Fridman E, Rosenwald S, Zilber S, Huang Y, Barshack I, Zion O, Mitchell H, Sanden M, Meiri E. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol Oncol 2013;7:732-8. [PMID: 23587442 DOI: 10.1016/j.molonc.2013.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
18 McDermott R, Gabikian P, Sarvaiya P, Ulasov I, Lesniak MS. MicroRNAs in brain metastases: big things come in small packages. J Mol Med (Berl) 2013;91:5-13. [PMID: 23138927 DOI: 10.1007/s00109-012-0971-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
19 Alsidawi S, Malek E, Driscoll JJ. MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. Int J Mol Sci 2014;15:10508-26. [PMID: 24921708 DOI: 10.3390/ijms150610508] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
20 Nourmohammadi B, Tafsiri E, Rahimi A, Nourmohammadi Z, Daneshvar Kakhaki A, Cho W, Karimipoor M. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. Asian Pac J Cancer Prev 2019;20:1633-9. [PMID: 31244281 DOI: 10.31557/APJCP.2019.20.6.1633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Xu SH, Yang YL, Han SM, Wu ZH. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J Surg Oncol 2014;12:195. [PMID: 24969351 DOI: 10.1186/1477-7819-12-195] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
22 Lu MY, Chen TY, Williamson DFK, Zhao M, Shady M, Lipkova J, Mahmood F. AI-based pathology predicts origins for cancers of unknown primary. Nature 2021;594:106-10. [PMID: 33953404 DOI: 10.1038/s41586-021-03512-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
23 Missiaglia E, Shepherd CJ, Aladowicz E, Olmos D, Selfe J, Pierron G, Delattre O, Walters Z, Shipley J. MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. Cancer Lett 2017;385:251-60. [PMID: 27984116 DOI: 10.1016/j.canlet.2016.10.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
24 Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol. 2012;14:689-700. [PMID: 22492962 DOI: 10.1093/neuonc/nos074] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 16.2] [Reference Citation Analysis]
25 Bhalala OG, Srikanth M, Kessler JA. The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol 2013;9:328-39. [PMID: 23588363 DOI: 10.1038/nrneurol.2013.67] [Cited by in Crossref: 175] [Cited by in F6Publishing: 163] [Article Influence: 19.4] [Reference Citation Analysis]
26 Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, Spector Y. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 2010;12:687-96. [PMID: 20595629 DOI: 10.2353/jmoldx.2010.090187] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
27 Li Q, Chang Y, Mu L, Song Y. MicroRNA-9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF-κB signaling pathway. Oncol Lett 2019;17:4819-26. [PMID: 31186688 DOI: 10.3892/ol.2019.10158] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Omahen DA. MicroRNA and Diseases of the Nervous System: . Neurosurgery 2011;69:440-54. [DOI: 10.1227/neu.0b013e318215a3b3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Gaebe K, Li AY, Das S. Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease. Cancers (Basel) 2021;13:5973. [PMID: 34885083 DOI: 10.3390/cancers13235973] [Reference Citation Analysis]
30 Chen X, Zhu L, Ma Z, Sun G, Luo X, Li M, Zhai S, Li P, Wang X. Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep 2015;5:17031. [PMID: 26593208 DOI: 10.1038/srep17031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
31 Uotani K, Fujiwara T, Yoshida A, Iwata S, Morita T, Kiyono M, Yokoo S, Kunisada T, Takeda K, Hasei J. Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma. Sci Rep. 2017;7:14634. [PMID: 29116117 DOI: 10.1038/s41598-017-12660-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
32 de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A, Pession A; PERNO Study Group. miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. PLoS One 2012;7:e35596. [PMID: 22530056 DOI: 10.1371/journal.pone.0035596] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
33 Nelson PT, Wilfred BR. In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain. Neurosci Lett 2009;466:69-72. [PMID: 19393719 DOI: 10.1016/j.neulet.2009.04.044] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
34 Chen Y, Zhang S, Zhao R, Zhao Q, Zhang T. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP. Oncol Res 2017;25:1215-22. [PMID: 27938505 DOI: 10.3727/096504016X14791715355957] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
35 Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. J Natl Cancer Inst 2013;105:1750-8. [PMID: 24168967 DOI: 10.1093/jnci/djt302] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 11.2] [Reference Citation Analysis]
36 de Planell-Saguer M, Rodicio MC. Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta. 2011;699:134-152. [PMID: 21704768 DOI: 10.1016/j.aca.2011.05.025] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 16.4] [Reference Citation Analysis]
37 Bhagirath D, Liston M, Akoto T, Lui B, Bensing BA, Sharma A, Saini S. Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients. Sci Rep 2021;11:8279. [PMID: 33859239 DOI: 10.1038/s41598-021-87441-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ben-Hamo R, Zilberberg A, Cohen H, Efroni S. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements. Oncotarget 2016;7:23170-81. [PMID: 27036038 DOI: 10.18632/oncotarget.6687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
39 Zhong Q, Wang T, Lu P, Zhang R, Zou J, Yuan S. miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res. 2014;92:619-626. [PMID: 24496888 DOI: 10.1002/jnr.23339] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
40 Navarrete K, Pedroso I, De Jong S, Stefansson H, Steinberg S, Stefansson K, Ophoff RA, Schalkwyk LC, Collier DA. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B Neuropsychiatr Genet 2013;162B:1-16. [PMID: 23129290 DOI: 10.1002/ajmg.b.32109] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
41 Jafari D, Tiyuri A, Rezaei E, Moradi Y, Jafari R, Jokar Shoorijeh F, Barati M. Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis. Expert Rev Mol Diagn 2020;20:1075-85. [PMID: 33131342 DOI: 10.1080/14737159.2020.1844006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tassinari M, Richter SN, Gandellini P. Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome. Nucleic Acids Res 2021;49:3617-33. [PMID: 33721024 DOI: 10.1093/nar/gkab127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
43 Gonçalves FZ, Lizarte Neto FS, Novais PC, Gattas D, Lourenço LG, de Carvalho CAM, Tirapelli DPC, Molina CAF, Tirapelli LF, Tucci S Jr. Expression profile of endothelin receptors (ETA and ETB) and microRNAs-155 and -199 in the corpus cavernosum of rats submitted to chronic alcoholism and diabetes mellitus. Braz J Med Biol Res 2018;51:e6329. [PMID: 29513879 DOI: 10.1590/1414-431X20176329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Sci Rep 2017;7:45283. [PMID: 28345661 DOI: 10.1038/srep45283] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
45 Galardi A, Colletti M, Di Paolo V, Vitullo P, Antonetti L, Russo I, Di Giannatale A. Exosomal MiRNAs in Pediatric Cancers. Int J Mol Sci 2019;20:E4600. [PMID: 31533332 DOI: 10.3390/ijms20184600] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
46 Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP, Meister G. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J 2011;30:4309-22. [PMID: 21857646 DOI: 10.1038/emboj.2011.301] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
47 Ahmed EK, Fahmy SA, Effat H, Wahab AHA. Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver. J Med Biochem 2019;38:109-17. [PMID: 30867638 DOI: 10.2478/jomb-2018-0010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
48 Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ, Lu X, Gross N, Kulesz-Martin M, Wang D. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 2012;48:73-78. [PMID: 22133638 DOI: 10.1016/j.oraloncology.2011.11.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
49 Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 2014;33:5017-27. [DOI: 10.1038/onc.2013.448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 8.2] [Reference Citation Analysis]
50 Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS. Brain Pathol 2012;22:522-9. [PMID: 22082152 DOI: 10.1111/j.1750-3639.2011.00551.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
51 Gilad S, Lithwick-Yanai G, Barshack I, Benjamin S, Krivitsky I, Edmonston TB, Bibbo M, Thurm C, Horowitz L, Huang Y. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn. 2012;14:510-517. [PMID: 22749746 DOI: 10.1016/j.jmoldx.2012.03.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
52 Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem. 2012;287:29516-29528. [PMID: 22761433 DOI: 10.1074/jbc.m111.335943] [Cited by in Crossref: 128] [Cited by in F6Publishing: 88] [Article Influence: 12.8] [Reference Citation Analysis]
53 Yu S, Liu X, Zhang Y, Li J, Chen S, Zheng H, Reng R, Zhang C, Chen J, Chen L. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Oncotarget 2016;7:84165-77. [PMID: 27705935 DOI: 10.18632/oncotarget.12389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
54 Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9:293-302. [PMID: 19262572 DOI: 10.1038/nrc2619] [Cited by in Crossref: 567] [Cited by in F6Publishing: 542] [Article Influence: 43.6] [Reference Citation Analysis]
55 González-Gómez P, Sánchez P, Mira H. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme. Mol Neurobiol. 2011;44:235-249. [PMID: 21728042 DOI: 10.1007/s12035-011-8196-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
56 Kim H, Kim T, Jaygal G, Woo J, Kim CJ, Baek MJ, Jeong D. Downregulation of miR-9 correlates with poor prognosis in colorectal cancer. Pathol Res Pract 2020;216:153044. [PMID: 32703504 DOI: 10.1016/j.prp.2020.153044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Kavanagh E, Joseph B. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta 2011;1816:50-6. [PMID: 21447370 DOI: 10.1016/j.bbcan.2011.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 47] [Article Influence: 1.6] [Reference Citation Analysis]
58 Kania EE, Carvajal-Moreno J, Hernandez VA, English A, Papa JL, Shkolnikov N, Ozer HG, Yilmaz AS, Yalowich JC, Elton TS. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide. Mol Pharmacol 2020;97:159-70. [PMID: 31836624 DOI: 10.1124/mol.119.118315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
59 Martinez M, Rossetto IMU, Arantes RMS, Lizarte FSN, Tirapelli LF, Tirapelli DPC, Chuffa LGA, Martinez FE. Serum miRNAs are differentially altered by ethanol and caffeine consumption in rats. Toxicol Res (Camb) 2019;8:842-9. [PMID: 32055392 DOI: 10.1039/c9tx00069k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Nikolova E, Georgiev C, Laleva L, Milev M, Spiriev T, Stoyanov S, Taseva-Mineva T, Mitev V, Todorova A. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives. Mol Genet Genomics 2022. [PMID: 35064290 DOI: 10.1007/s00438-021-01851-5] [Reference Citation Analysis]
61 Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010;6:e1000879. [PMID: 20300657 DOI: 10.1371/journal.pgen.1000879] [Cited by in Crossref: 316] [Cited by in F6Publishing: 300] [Article Influence: 26.3] [Reference Citation Analysis]
62 Mirihana Arachchilage G, Dassanayake AC, Basu S. A potassium ion-dependent RNA structural switch regulates human pre-miRNA 92b maturation. Chem Biol 2015;22:262-72. [PMID: 25641166 DOI: 10.1016/j.chembiol.2014.12.013] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 10.7] [Reference Citation Analysis]
63 Zhao K, Liang G, Sun X, Guan le L. Comparative miRNAome analysis revealed different miRNA expression profiles in bovine sera and exosomes. BMC Genomics. 2016;17:630. [PMID: 27519500 DOI: 10.1186/s12864-016-2962-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
64 Galuppini F, Censi S, Moro M, Carraro S, Sbaraglia M, Iacobone M, Fassan M, Mian C, Pennelli G. MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives. Cells 2021;10:955. [PMID: 33924120 DOI: 10.3390/cells10040955] [Reference Citation Analysis]
65 Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L, Luo H, Peng X, Li G, Tian W, He M, Li X. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer 2014;110:392-8. [PMID: 24327016 DOI: 10.1038/bjc.2013.751] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
66 Zhao HM, Wei W, Sun YH, Gao JH, Wang Q, Zheng JH. MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells. Tumour Biol 2015;36:6867-73. [PMID: 25846738 DOI: 10.1007/s13277-015-3399-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
67 Zhang X, Zheng Y, Jagadeeswaran G, Ren R, Sunkar R, Jiang H. Identification and developmental profiling of conserved and novel microRNAs in Manduca sexta. Insect Biochem Mol Biol 2012;42:381-95. [PMID: 22406339 DOI: 10.1016/j.ibmb.2012.01.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
68 Ogata K, Sumida K, Miyata K, Kushida M, Kuwamura M, Yamate J. Circulating miR-9* and miR-384-5p as potential indicators for trimethyltin-induced neurotoxicity. Toxicol Pathol 2015;43:198-208. [PMID: 24777749 DOI: 10.1177/0192623314530533] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
69 Somel M, Liu X, Tang L, Yan Z, Hu H, Guo S, Jiang X, Zhang X, Xu G, Xie G, Li N, Hu Y, Chen W, Pääbo S, Khaitovich P. MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol 2011;9:e1001214. [PMID: 22162950 DOI: 10.1371/journal.pbio.1001214] [Cited by in Crossref: 148] [Cited by in F6Publishing: 133] [Article Influence: 13.5] [Reference Citation Analysis]
70 Seoane J, De Mattos-Arruda L. Brain metastasis: new opportunities to tackle therapeutic resistance. Mol Oncol 2014;8:1120-31. [PMID: 24953014 DOI: 10.1016/j.molonc.2014.05.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
71 Riaz M, van Jaarsveld MT, Hollestelle A, Prager-van der Smissen WJ, Heine AA, Boersma AW, Liu J, Helmijr J, Ozturk B, Smid M, Wiemer EA, Foekens JA, Martens JW. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res 2013;15:R33. [PMID: 23601657 DOI: 10.1186/bcr3415] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 13.3] [Reference Citation Analysis]
72 Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. Significance and therapeutic value of miRNAs in embryonal neural tumors. Molecules 2014;19:5821-62. [PMID: 24806581 DOI: 10.3390/molecules19055821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
73 Zhou B, Xu H, Xia M, Sun C, Li N, Guo E, Guo L, Shan W, Lu H, Wu Y, Li Y, Yang D, Weng D, Meng L, Hu J, Ma D, Chen G, Li K. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer. Front Med 2017;11:214-22. [DOI: 10.1007/s11684-017-0518-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
74 Yuan Z, Sun X, Liu H, Xie J. MicroRNA genes derived from repetitive elements and expanded by segmental duplication events in mammalian genomes. PLoS One 2011;6:e17666. [PMID: 21436881 DOI: 10.1371/journal.pone.0017666] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
75 Godlewski J, Newton HB, Chiocca EA, Lawler SE. MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ 2010;17:221-8. [PMID: 19521422 DOI: 10.1038/cdd.2009.71] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 6.0] [Reference Citation Analysis]
76 Cava C, Colaprico A, Bertoli G, Bontempi G, Mauri G, Castiglioni I. How interacting pathways are regulated by miRNAs in breast cancer subtypes. BMC Bioinformatics 2016;17:348. [PMID: 28185585 DOI: 10.1186/s12859-016-1196-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
77 Zhou Q, Liu J, Quan J, Liu W, Tan H, Li W. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis. Cancer Sci 2018;109:2651-9. [PMID: 29949235 DOI: 10.1111/cas.13714] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 14.3] [Reference Citation Analysis]
78 Stampone E, Caldarelli I, Zullo A, Bencivenga D, Mancini FP, Della Ragione F, Borriello A. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases. Int J Mol Sci 2018;19:E1055. [PMID: 29614816 DOI: 10.3390/ijms19041055] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
79 White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol. 2011;8:75-84. [PMID: 21045789 DOI: 10.1038/nrclinonc.2010.173] [Cited by in Crossref: 136] [Cited by in F6Publishing: 134] [Article Influence: 11.3] [Reference Citation Analysis]
80 Khosravi A, Alizadeh S, Jalili A, Shirzad R, Saki N. The impact of Mir-9 regulation in normal and malignant hematopoiesis. Oncol Rev 2018;12:348. [PMID: 29774136 DOI: 10.4081/oncol.2018.348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
81 Eguía-Aguilar P, Gutiérrez-Castillo L, Pérezpeña-Díazconti M, García-Chéquer J, García-Quintana J, Chico-Ponce de León F, Gordillo-Domínguez L, Torres-García S, Arenas-Huertero F. Expression of microRNAs in tumors of the central nervous system in pediatric patients in México. Childs Nerv Syst 2017;33:2117-28. [PMID: 28815380 DOI: 10.1007/s00381-017-3569-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol. 2012;29:1037-1043. [PMID: 21562850 DOI: 10.1007/s12032-011-9975-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
83 Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen X, Wang J, Lu F. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog 2016;55:732-42. [PMID: 25809226 DOI: 10.1002/mc.22317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
84 Chen X, Zhou Y, Wan Y, Chen T, Zhu H, Cheng X. The expression of NLK is functionally associated with colorectal cancers (CRC). J Cancer 2021;12:7088-100. [PMID: 34729110 DOI: 10.7150/jca.62526] [Reference Citation Analysis]
85 Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011;6:e16915. [PMID: 21364938 DOI: 10.1371/journal.pone.0016915] [Cited by in Crossref: 240] [Cited by in F6Publishing: 217] [Article Influence: 21.8] [Reference Citation Analysis]
86 Báez-Vega PM, Echevarría Vargas IM, Valiyeva F, Encarnación-Rosado J, Roman A, Flores J, Marcos-Martínez MJ, Vivas-Mejía PE. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Oncotarget 2016;7:36321-37. [PMID: 27166999 DOI: 10.18632/oncotarget.9216] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
87 Ao R, Wang Y, Tong J, Wang BF. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Med Sci Monit. 2016;22:3804-3819. [PMID: 27756894 DOI: 10.12659/msm.897207] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H. Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary. Mol Cancer. 2013;12:57. [PMID: 23758919 DOI: 10.1186/1476-4598-12-57] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
89 Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer. 2012;51:1-9. [PMID: 21922590 DOI: 10.1002/gcc.20925] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
90 Biswas S, Rao CM. Epigenetics in cancer: Fundamentals and Beyond. Pharmacol Ther 2017;173:118-34. [PMID: 28188812 DOI: 10.1016/j.pharmthera.2017.02.011] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 21.0] [Reference Citation Analysis]
91 Lozada-Delgado EL, Grafals-Ruiz N, Vivas-Mejía PE. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials. Life Sci 2017;188:26-36. [PMID: 28864225 DOI: 10.1016/j.lfs.2017.08.027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
92 Wang JH, He DE. Simvastatin treatment promotes proliferation of human dental pulp stem cells via modulating PI3K/AKT/miR-9/KLF5 signalling pathway. J Cell Mol Med 2021;25:10892-901. [PMID: 34799978 DOI: 10.1111/jcmm.16973] [Reference Citation Analysis]
93 Roese-Koerner B, Stappert L, Brüstle O. Notch/Hes signaling and miR-9 engage in complex feedback interactions controlling neural progenitor cell proliferation and differentiation. Neurogenesis (Austin) 2017;4:e1313647. [PMID: 28573150 DOI: 10.1080/23262133.2017.1313647] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
94 Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. Mol Cancer 2013;12:173. [PMID: 24373626 DOI: 10.1186/1476-4598-12-173] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
95 Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S, Anderson LM, Perantoni AO, Phang JM. miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 2010;29:4914-24. [PMID: 20562915 DOI: 10.1038/onc.2010.237] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.9] [Reference Citation Analysis]
96 Song Y, Mu L, Han X, Li Q, Dong B, Li H, Liu X. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression. J Neurooncol 2013;115:381-90. [PMID: 24043603 DOI: 10.1007/s11060-013-1245-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
97 Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J, Zhang YQ, Shi JW, Lin XL, Yang S. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2013;431:610-616. [PMID: 23291181 DOI: 10.1016/j.bbrc.2012.12.097] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 9.1] [Reference Citation Analysis]
98 Wang H, Wu Q, Zhang Y, Zhang HN, Wang YB, Wang W. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Cell Mol Biol Lett 2017;22:22. [PMID: 29118814 DOI: 10.1186/s11658-017-0053-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
99 Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K, Tong Q. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 2013;8:e55719. [PMID: 23383271 DOI: 10.1371/journal.pone.0055719] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 10.6] [Reference Citation Analysis]
100 Pentheroudakis G, Spector Y, Krikelis D, Kotoula V, Meiri E, Malamou-mitsi V, Fountzilas G, Sanden M, Pavlidis N, Benjamin H, Aharonov R. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors. Clin Exp Metastasis 2013;30:431-9. [DOI: 10.1007/s10585-012-9548-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
101 Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12:247-256. [PMID: 20173740 DOI: 10.1038/ncb2024] [Cited by in Crossref: 921] [Cited by in F6Publishing: 899] [Article Influence: 76.8] [Reference Citation Analysis]
102 Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 2012;226:61-72. [PMID: 22131135 DOI: 10.1002/path.2964] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 9.6] [Reference Citation Analysis]
103 Catuogno S, Esposito CL, Quintavalle C, Condorelli G, de Franciscis V, Cerchia L. Nucleic acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 2012;2012:735135. [PMID: 22685651 DOI: 10.1155/2012/735135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
104 Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest 2012;122:33-47. [PMID: 22156201 DOI: 10.1172/JCI58849] [Cited by in Crossref: 115] [Cited by in F6Publishing: 78] [Article Influence: 10.5] [Reference Citation Analysis]
105 Zhang H, Zhang Z, Wang S, Zhang S, Bi J. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3. Biomedicine & Pharmacotherapy 2018;102:626-32. [DOI: 10.1016/j.biopha.2018.03.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
106 Pang JC, Kwok WK, Chen Z, Ng HK. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 2009;117:599-611. [PMID: 19343354 DOI: 10.1007/s00401-009-0525-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 6.5] [Reference Citation Analysis]
107 Zhang X, Qian Y, Li F, Bei S, Li M, Feng L. microRNA-9 selectively targets LMX1A to promote gastric cancer cell progression. Biochemical and Biophysical Research Communications 2018;505:405-12. [DOI: 10.1016/j.bbrc.2018.09.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
108 Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion O, Strenov Y. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract. 2010;206:578-584. [PMID: 20418022 DOI: 10.1016/j.prp.2010.03.005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
109 Senyuk V, Zhang Y, Liu Y, Ming M, Premanand K, Zhou L, Chen P, Chen J, Rowley JD, Nucifora G, Qian Z. Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis. Proc Natl Acad Sci U S A 2013;110:5594-9. [PMID: 23509296 DOI: 10.1073/pnas.1302645110] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
110 Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W, Zhang LJ. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol. 2010;27:654-660. [PMID: 19572217 DOI: 10.1007/s12032-009-9264-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
111 Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan R, Zhan H, Liu J, Wang J. miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour Biol 2015;36:9631-40. [PMID: 26150338 DOI: 10.1007/s13277-015-3713-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
112 Song H, Zhang Y, Liu N, Wan C, Zhang D, Zhao S, Kong Y, Yuan L. miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway. J Physiol Biochem 2016;72:201-11. [PMID: 26893028 DOI: 10.1007/s13105-016-0470-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
113 Wu Z, Wang L, Li G, Liu H, Fan F, Li Z, Li Y, Gao G. Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma. Mol Cell Biochem 2013;384:263-8. [PMID: 24122417 DOI: 10.1007/s11010-013-1805-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
114 Su Y, Li X, Ji W, Sun B, Xu C, Li Z, Qian G, Su C. Small molecule with big role: MicroRNAs in cancer metastatic microenvironments. Cancer Lett 2014;344:147-56. [PMID: 24184826 DOI: 10.1016/j.canlet.2013.10.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
115 Nakano T, Chen I, Wang C, Chen P, Tseng H, Huang K, Hu T, Li L, Goto S, Cheng Y, Lin C, Chen C. Circulating exosomal miR‐92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Am J Transplant 2019;19:3250-62. [DOI: 10.1111/ajt.15490] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
116 Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA sequences in human disease. Mutat Res 2012;731:14-9. [PMID: 22085809 DOI: 10.1016/j.mrfmmm.2011.10.014] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
117 Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011;89:445-57. [PMID: 21234533 DOI: 10.1007/s00109-010-0716-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 80] [Article Influence: 9.1] [Reference Citation Analysis]
118 Lang W, Chen F. The reciprocal link between EVI1 and miRNAs in human malignancies. Gene 2018;672:56-63. [DOI: 10.1016/j.gene.2018.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
119 Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L, Wang H, Qin Y, Zeng M, Guan XY, Li Y. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma. Oncotarget. 2014;5:11669-11680. [PMID: 25375090 DOI: 10.18632/oncotarget.2581] [Cited by in Crossref: 69] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
120 Xu A, Chen J, Peng H, Han G, Cai H. Simultaneous Interrogation of Cancer Omics to Identify Subtypes With Significant Clinical Differences. Front Genet 2019;10:236. [PMID: 30984238 DOI: 10.3389/fgene.2019.00236] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
121 Li X, He L, Yue Q, Lu J, Kang N, Xu X, Wang H, Zhang H. MiR-9-5p promotes MSC migration by activating β-catenin signaling pathway. Am J Physiol Cell Physiol 2017;313:C80-93. [PMID: 28424168 DOI: 10.1152/ajpcell.00232.2016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
122 Nishioka C, Ikezoe T, Pan B, Xu K, Yokoyama A. MicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cells. Cancer Sci 2017;108:685-95. [PMID: 28107581 DOI: 10.1111/cas.13170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
123 Renner M, Czwan E, Hartmann W, Penzel R, Brors B, Eils R, Wardelmann E, Büttner R, Lichter P, Schirmacher P, Mechtersheimer G. MicroRNA profiling of primary high-grade soft tissue sarcomas. Genes Chromosomes Cancer 2012;51:982-96. [PMID: 22811003 DOI: 10.1002/gcc.21980] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
124 Li X, Xu X, Chen K, Wu H, Wang Y, Yang S, Wang K. miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma. Pathol Oncol Res 2020;26:707-14. [PMID: 30712191 DOI: 10.1007/s12253-019-00605-4] [Reference Citation Analysis]
125 Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, Litman T, Ditzel HJ. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat. 2012;134:207-217. [PMID: 22294488 DOI: 10.1007/s10549-012-1969-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
126 Li Q, Shen K, Zhao Y, Ma C, Liu J, Ma J. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. J Transl Med 2013;11:302. [PMID: 24325785 DOI: 10.1186/1479-5876-11-302] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
127 Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y, Zhou LF. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Brain Res 2013;1529:16-25. [PMID: 23892108 DOI: 10.1016/j.brainres.2013.07.031] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
128 Fromm B, Billipp T, Peck LE, Johansen M, Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E, Peterson KJ. A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome. Annu Rev Genet. 2015;49:213-242. [PMID: 26473382 DOI: 10.1146/annurev-genet-120213-092023] [Cited by in Crossref: 302] [Cited by in F6Publishing: 264] [Article Influence: 43.1] [Reference Citation Analysis]
129 Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB, Fang ZY, Cui SZ, Wang LT. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World J Gastroenterol 2014; 20(32): 11347-11355 [PMID: 25170221 DOI: 10.3748/wjg.v20.i32.11347] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
130 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
131 Wang LQ, Chim CS. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics 2015;7:461-73. [PMID: 25650645 DOI: 10.2217/epi.15.6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]